• Is Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock worth buying before Fed action - Weekly Stock Report & AI Forecasted Ent... newser.com Mon, 17 Nov 2025 19:02:04 GMT
• Will Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock benefit from commodity supercycle - 2025 Short Interest & Verified Tec... newser.com Sun, 16 Nov 2025 16:57:33 GMT
• Will Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock benefit from Fed rate cuts - Stop Loss & Stepwise Trade Signal Impleme... newser.com Sat, 15 Nov 2025 17:48:27 GMT
• Will Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock announce special dividend - July 2025 WrapUp & Daily Profit Focused St... newser.com Fri, 14 Nov 2025 10:43:10 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock benefit from commodity supercycle - weekly stock analysis & verified c... newser.com Thu, 13 Nov 2025 18:40:36 GMT
• Can Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock survive global slowdown - 2025 Trading Volume Trends & Fast Moving Trad... newser.com Wed, 12 Nov 2025 04:34:36 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock benefit from commodity supercycle - profit target & fast gaining stock... newser.com Tue, 11 Nov 2025 15:35:32 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock benefit from commodity supercycle - july 2025 review & technical buy z... newser.com Mon, 10 Nov 2025 08:06:04 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock announce special dividend - market risk report & real-time buy signal ... newser.com Sun, 09 Nov 2025 03:00:48 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock benefit from commodity supercycle - 2025 alltime highs & verified char... newser.com Sat, 08 Nov 2025 06:58:55 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock benefit from commodity supercycle - july 2025 analyst calls & intraday... newser.com Fri, 07 Nov 2025 15:28:48 GMT
• chemomab announces presentations at aasld 2025 on nebokitug data TipRanks Thu, 06 Nov 2025 13:59:14 GMT
• can chemomab therapeutics ltd. (common stock) (2qv0) stock survive global slowdown - 2025 sector review & high yield stock recomme... newser.com Thu, 06 Nov 2025 09:25:27 GMT
• Chemomab reports positive 48-week data for PSC drug nebokitug Investing.com Thu, 06 Nov 2025 08:00:00 GMT
• Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Tria... Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
• chemomab therapeutics (cmmb) projected to post earnings on thursday Defense World Thu, 06 Nov 2025 07:46:37 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock announce special dividend - market volume report & daily growth stock ... Fundação Cultural do Pará Thu, 06 Nov 2025 06:38:50 GMT
• What dividend safety rating applies to Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock - Swing Trade & Reliable Intraday Tr... newser.com Thu, 06 Nov 2025 05:35:08 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock announce special dividend - quarterly profit report & risk controlled ... newser.com Wed, 05 Nov 2025 06:36:18 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock announce special dividend - weekly profit summary & verified swing tra... newser.com Tue, 04 Nov 2025 08:33:02 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock benefit from fed rate cuts - 2025 stock rankings & daily market moment... newser.com Mon, 03 Nov 2025 06:38:18 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock announce special dividend - ceo change & fast momentum stock entry tip... newser.com Sun, 02 Nov 2025 08:29:50 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - july 2025 short interest & long-te... newser.com Fri, 31 Oct 2025 09:47:38 GMT
• can chemomab therapeutics ltd. (common stock) (2qv0) stock survive global slowdown - 2025 fundamental recap & fast gain swing trad... newser.com Fri, 31 Oct 2025 06:33:30 GMT
• can chemomab therapeutics ltd. (common stock) (2qv0) stock survive global slowdown - weekly stock report & high accuracy swing tra... newser.com Thu, 30 Oct 2025 14:50:25 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock announce special dividend - market volume summary & safe capital growt... newser.com Thu, 30 Oct 2025 12:00:18 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock benefit from fed rate cuts - 2025 volatility report & ai driven stock ... newser.com Tue, 28 Oct 2025 05:09:59 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - 2025 alltime highs & low drawdown ... newser.com Tue, 28 Oct 2025 04:44:30 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - july 2025 endofmonth & high convic... newser.com Mon, 27 Oct 2025 22:42:44 GMT
• can chemomab therapeutics ltd. (common stock) (2qv0) stock sustain breakout momentum - portfolio profit report & expert-curated tr... fcp.pa.gov.br Mon, 27 Oct 2025 21:37:44 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - 2025 macro impact & consistent inc... newser.com Sun, 26 Oct 2025 19:16:41 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - oil prices & fast entry and exit t... newser.com Sat, 25 Oct 2025 17:43:40 GMT
• ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition TradingView Thu, 23 Oct 2025 07:00:00 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock benefits from digital adoption - trade exit summary & technical confirm... newser.com Thu, 23 Oct 2025 06:54:13 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock remains top rated - july 2025 levels & verified swing trading watchlist... newser.com Wed, 22 Oct 2025 02:42:38 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock responds to bond market - trade performance summary & community verifie... newser.com Wed, 22 Oct 2025 02:27:46 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock benefits from digital adoption - 2025 technical patterns & risk control... newser.com Tue, 21 Oct 2025 21:43:46 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - analyst downgrade & safe capital g... newser.com Tue, 21 Oct 2025 18:50:38 GMT
• is chemomab therapeutics ltd. (common stock) (2qv0) stock a buy on weakness - 2025 year in review & real-time buy zone alerts newser.com Tue, 21 Oct 2025 06:52:19 GMT
• is chemomab therapeutics ltd. (common stock) (2qv0) stock a buy on weakness - market risk summary & verified trade idea suggestion... Trung tâm Dự báo KTTV quốc gia Mon, 20 Oct 2025 13:53:49 GMT
• us market recap: can chemomab therapeutics ltd. (common stock) (2qv0) stock sustain breakout momentum - ipo watch & technical anal... Trung tâm Dự báo KTTV quốc gia Mon, 20 Oct 2025 13:16:01 GMT
• can chemomab therapeutics ltd. (common stock) (2qv0) stock sustain breakout momentum - ipo watch & technical analysis for trade co... nchmf.gov.vn Mon, 20 Oct 2025 13:16:01 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock responds to bond market - july 2025 final week & risk adjusted buy and ... newser.com Mon, 20 Oct 2025 12:02:39 GMT
• will chemomab therapeutics ltd. (common stock) (2qv0) stock outperform benchmarks - long setup & fast exit and entry strategy plan... Trung tâm Dự báo KTTV quốc gia Mon, 20 Oct 2025 04:48:52 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock responds to bond market - market growth review & community consensus tr... newser.com Sun, 19 Oct 2025 07:09:52 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock responds to bond market - trade entry summary & proven capital preserva... newser.com Sat, 18 Oct 2025 23:30:06 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock gets analyst attention - market movement recap & free high return stock... Trung tâm Dự báo KTTV quốc gia Sat, 18 Oct 2025 13:49:15 GMT
• gains report: why chemomab therapeutics ltd. (common stock) (2qv0) stock gets analyst attention - weekly stock report & daily mark... nchmf.gov.vn Fri, 17 Oct 2025 17:39:28 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock gets analyst attention - weekly stock report & daily market momentum tr... nchmf.gov.vn Fri, 17 Oct 2025 17:39:28 GMT
• espr aims to diversify with rare liver disease candidate, stock up Zacks Investment Research Fri, 17 Oct 2025 15:01:47 GMT
• CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer TradingView Wed, 15 Oct 2025 07:00:00 GMT
• TVRD Stock Plunges 84% After Phase II Fibrosis Study Misses Key Goals Zacks Investment Research Tue, 14 Oct 2025 07:00:00 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock stays on top picks - market activity recap & free weekly chart analysis... newser.com Tue, 14 Oct 2025 05:11:24 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock is listed among top recommendations - earnings recap report & ai driven... newser.com Mon, 13 Oct 2025 08:12:32 GMT
• chemomab therapeutics (nasdaq:cmmb) upgraded by wall street zen to “hold” rating Defense World Sat, 11 Oct 2025 07:00:00 GMT
• KALA Stock Crashes 88% in a Month Following Eye Disorder Study Failure TradingView Wed, 08 Oct 2025 07:00:00 GMT
• is chemomab therapeutics ltd common stock 2qv0 a good long term investment - price support zones & free trend following techniques... earlytimes.in Tue, 07 Oct 2025 20:14:22 GMT
• MRK Expands Tulisokibart Program in Three New Inflammatory Diseases Zacks Investment Research Tue, 07 Oct 2025 07:00:00 GMT
• what analysts say about chemomab therapeutics ltd common stock 2qv0 stock - trading volume surges & market-leading growth rates earlytimes.in Mon, 06 Oct 2025 14:39:43 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - weekly trade recap & weekly hot st... newser.com Mon, 06 Oct 2025 12:00:58 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock is listed among top recommendations - trade risk summary & long-term ca... newser.com Mon, 06 Oct 2025 07:34:30 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - market rally & free risk controlle... newser.com Sun, 05 Oct 2025 09:58:37 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock is listed among top recommendations - trade risk summary & long-term ca... newser.com Fri, 03 Oct 2025 05:34:59 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - 2025 trade ideas & consistent grow... newser.com Wed, 01 Oct 2025 14:34:03 GMT
• primary sclerosing cholangitis pipeline 2025: fda updates, openPR.com Tue, 30 Sep 2025 07:00:00 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock responds to bond market - 2025 retail activity & weekly high momentum p... newser.com Tue, 30 Sep 2025 05:46:24 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock stays on top picks - analyst downgrade & weekly top gainers alerts newser.com Tue, 30 Sep 2025 04:40:01 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock is listed among top recommendations - jobs report & weekly breakout opp... newser.com Mon, 29 Sep 2025 22:40:05 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock responds to bond market newser.com Mon, 29 Sep 2025 19:09:00 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - trend reversal & accurate intraday... newser.com Mon, 29 Sep 2025 17:04:24 GMT
• is chemomab therapeutics ltd common stock 2qv0 a good long term investment - covered call writing & rapid capital trading plans earlytimes.in Sun, 28 Sep 2025 22:56:47 GMT
• what analysts say about chemomab therapeutics ltd common stock 2qv0 stock - stock rotation strategies & small capital investment t... earlytimes.in Sun, 28 Sep 2025 08:15:06 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock remains top rated - earnings risk summary & reliable price breakout sig... newser.com Sun, 28 Sep 2025 01:40:21 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock responds to bond market - 2025 price action summary & long-term growth ... newser.com Sat, 27 Sep 2025 21:48:43 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - july 2025 summary & proven capital... newser.com Sat, 27 Sep 2025 19:10:05 GMT
• what dividend safety rating applies to chemomab therapeutics ltd. (common stock) (2qv0) stock - weekly gains report & growth focus... newser.com Fri, 26 Sep 2025 20:25:51 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock responds to bond market - exit point & smart investment allocation insi... newser.com Fri, 26 Sep 2025 18:47:25 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock is listed among top recommendations - july 2025 wrapup & daily volume s... newser.com Fri, 26 Sep 2025 17:29:48 GMT
• chemomab therapeutics announces first quarter 2022 financial results and provides corporate update PR Newswire Thu, 25 Sep 2025 06:10:00 GMT
• oppenheimer raises chemomab stock price target to $25 on m&a potential by investing.com Investing.com Australia Thu, 28 Aug 2025 07:00:00 GMT
• oppenheimer maintains chemomab therapeutics(cmmb.us) with buy rating, raises target price to $25 富途牛牛 Thu, 28 Aug 2025 07:00:00 GMT
• Oppenheimer raises Chemomab stock price target to $25 on M&A potential Investing.com Wed, 27 Aug 2025 07:00:00 GMT
• oppenheimer maintains chemomab therapeutics(cmmb.us) with buy rating, raises target price to $25 富途牛牛 Wed, 27 Aug 2025 07:00:00 GMT
• chemomab therapeutics price target raised to $25 from $10 at oppenheimer TipRanks Wed, 27 Aug 2025 07:00:00 GMT
• Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025 TipRanks Tue, 26 Aug 2025 07:00:00 GMT
• chemomab therapeutics price target raised to $25 from $10 at oppenheimer MSN Tue, 26 Aug 2025 07:00:00 GMT
• chemomab therapeutics announces ads ratio change effective august 26, 2025 TipRanks Mon, 25 Aug 2025 00:14:43 GMT
• chemomab therapeutics announces ads ratio change effective august 26, 2025 The Globe and Mail Sat, 23 Aug 2025 20:30:00 GMT
• chemomab announces appointment of mitchell l. jones, md, phd as vice president of corporate development & strategy Quantisnow Sat, 23 Aug 2025 01:29:04 GMT
• chemomab therapeutics announces ads ratio change effective august 26, 2025 TipRanks Fri, 22 Aug 2025 20:28:39 GMT
• chemomab to present at h.c. wainwright global investment conference sept. 5. AInvest Thu, 21 Aug 2025 12:06:34 GMT
• Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference Yahoo Finance Thu, 21 Aug 2025 07:00:00 GMT
• clinical-stage biotech chemomab to showcase fibro-inflammatory pipeline at global investment conference Stock Titan Thu, 21 Aug 2025 07:00:00 GMT
• Chemomab, FDA align on key aspects of nebokitug development Liver Disease News Wed, 20 Aug 2025 07:00:00 GMT
• maxim group maintains chemomab therapeutics(cmmb.us) with buy rating, maintains target price $7 富途牛牛 Fri, 15 Aug 2025 07:00:00 GMT
• chemomab therapeutics: advancing cm-101 with strategic financial optimizations and fda support TipRanks Fri, 15 Aug 2025 07:00:00 GMT
• chemomab therapeutics announces second quarter 2025 financial results and provides corporate update GlobeNewswire Fri, 15 Aug 2025 04:35:50 GMT
• Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update Yahoo Finance Thu, 14 Aug 2025 07:00:00 GMT
• chemomab's psc drug nebokitug gets fda backing for phase 3 program as company seeks strategic partner Stock Titan Thu, 14 Aug 2025 07:00:00 GMT
• chemomab therapeutics reports q2 eps 0.4c vs 0.013c last year TipRanks Thu, 14 Aug 2025 07:00:00 GMT
• chemomab therapeutics to carry out 1-for-4 reverse stock split on august 26th, 2025 富途牛牛 Sat, 09 Aug 2025 07:02:56 GMT
• Chemomab Therapeutics To Carry Out 1-for-4 Reverse Stock Split On August 26th, 2025 富途牛牛 Fri, 08 Aug 2025 07:00:00 GMT
• mersana therapeutics (nasdaq:mrsn) and chemomab therapeutics (nasdaq:cmmb) head to head analysis Defense World Tue, 05 Aug 2025 07:00:00 GMT
• chemomab therapeutics enters sales agreement with lifesci capital The Globe and Mail Sat, 26 Jul 2025 07:00:00 GMT
• chemomab therapeutics enters sales agreement with lifesci capital TipRanks Fri, 25 Jul 2025 07:00:00 GMT
• chemomab therapeutics announces key decisions from annual shareholders meeting, ceo awarded restricted share units AInvest Wed, 02 Jul 2025 07:00:00 GMT
• chemomab therapeutics announces key decisions from annual shareholders meeting TipRanks Tue, 01 Jul 2025 07:00:00 GMT
• chemomab therapeutics announces data from phase 2 spring trial of nebokitug TipRanks Tue, 01 Jul 2025 06:50:57 GMT
• Chemomab Therapeutics Announces Positive Phase 2 SPRING Trial Results for Nebokitug as Promising Treatment for Primary Sclerosing ... Nasdaq Mon, 30 Jun 2025 07:00:00 GMT
• chemomab announces oral presentation of positive nebokitug phase 2 clinical data in primary sclerosing cholangitis at bsg live’25 GlobeNewswire Mon, 30 Jun 2025 07:00:00 GMT
• breakthrough psc treatment: nebokitug phase 2 data shows multiple disease-modifying benefits Stock Titan Mon, 30 Jun 2025 07:00:00 GMT
• chemomab therapeutics announces data from phase 2 spring trial of nebokitug TipRanks Mon, 30 Jun 2025 07:00:00 GMT
• chemomab therapeutics, ltd. announces oral presentation of positive nebokitug phase 2 clinical data in primary sclerosing cholangi... MarketScreener Mon, 30 Jun 2025 07:00:00 GMT
• cmmb’s market whiplash: -34.81% ytd decline, -15.11% plunge in 30 days investchronicle.com Wed, 18 Jun 2025 07:00:00 GMT
• chemomab therapeutics (nasdaq:cmmb) shares up 2.5% – time to buy? Defense World Tue, 17 Jun 2025 07:00:00 GMT
• chemomab therapeutics advances phase 3 development with fda approval on key milestones AInvest Sun, 15 Jun 2025 07:00:00 GMT
• chemomab obtained feedback from two recent fda meetings on nebokitug TipRanks Wed, 11 Jun 2025 19:31:38 GMT
• chemomab reports positive feedback from two recent fda meetings supporting phase 3 advancement of nebokitug in primary sclerosing ... GlobeNewswire Wed, 11 Jun 2025 07:00:00 GMT
• fda backs chemomab's nebokitug phase 3 plans: major regulatory win for psc treatment Stock Titan Wed, 11 Jun 2025 07:00:00 GMT
• cmmb advances toward phase 3 with fda approval on key milestones GuruFocus Wed, 11 Jun 2025 07:00:00 GMT
• chemomab therapeutics to present at the h.c. wainwright 25th annual global investment conference The Globe and Mail Tue, 10 Jun 2025 18:26:54 GMT
• chemomab announces nebokitug awarded new patent protection in china, russia TipRanks Tue, 03 Jun 2025 13:44:40 GMT
• chemomab therapeutics says nebokitug awarded new patent protections in china, russia MarketScreener Tue, 03 Jun 2025 12:43:46 GMT
• cmmb gains new patent protections for lead product nebokitug | cmmb stock news GuruFocus Tue, 03 Jun 2025 12:17:19 GMT
• chemomab announces new patent awards for its first-in-class GlobeNewswire Tue, 03 Jun 2025 07:00:00 GMT
• breakthrough psc drug patent: chemomab's nebokitug could be first-ever treatment for fatal liver disease Stock Titan Tue, 03 Jun 2025 07:00:00 GMT
• rckt stock tanks on patient death in danon disease study The Globe and Mail Wed, 28 May 2025 07:00:00 GMT
• chemomab therapeutics announces annual general meeting for july 2025 TipRanks Tue, 27 May 2025 07:00:00 GMT
• chemomab prepares for annual shareholder meeting by investing.com Investing.com Canada Tue, 27 May 2025 07:00:00 GMT
• chemomab therapeutics (nasdaq:cmmb) shares up 0.4% – should you buy? Defense World Sat, 24 May 2025 18:15:24 GMT
• oppenheimer issues pessimistic forecast for chemomab therapeutics (nasdaq:cmmb) stock price Defense World Sun, 18 May 2025 06:46:57 GMT
• chemomab therapeutics: promising prospects with streamlined path to approval and strategic advancements TipRanks Sat, 17 May 2025 17:59:33 GMT
• chemomab therapeutics price target lowered to $10 from $11 at oppenheimer TipRanks Sat, 17 May 2025 10:48:12 GMT
• oppenheimer maintains outperform rating on chemomab therapeutics, lowers price target to $10.00 usd. AInvest Sat, 17 May 2025 07:00:00 GMT
Chemomab Therapeutics Ltd(NASDAQ:CMMB) 
Chemomab Therapeutics Ltd. engages in the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 16, 2021. Chemomab Therapeutics Ltd...
Share this website to your friends